To determine the contribution of p53, a primary effector of the anti-proliferative response that is often triggered by dysfunctional RiBi to the liver disease caused by Rps6-deficiency, we find that forced activation of p53 inhibits bile duct development, but that the disease in Rps6-deficient livers is not solely p53-dependent. The gene discussed is RPS6; the disease is liver disorder.